Navigation Links
Nature study shows how molecules escape from the nucleus
Date:9/16/2010

and the observation that 10 percent of messenger RNA molecules sit for seconds at nuclear pores without gaining entry, suggest that messenger RNA could be screened for quality at this point.

"Researchers have speculated that messenger RNA molecules that are defective in some way, perhaps because the genes they're derived from are mutated, may be inspected and destroyed before getting into the cytoplasm or a short time later, and the question has been, 'Where might that surveillance be happening?'," said Dr. Singer. "So we're wondering if those messenger RNA molecules that couldn't get through the nuclear pores were subjected to a quality control mechanism that didn't give them a clean bill of health for entry."

In previous research, Dr. Singer studied myotonic dystrophy, a severe inherited disorder marked by wasting of the muscles and caused by a mutation involving repeated DNA sequences of three nucleotides. Dr. Singer found that in the cells of people with myotonic dystrophy, messenger RNA gets stuck in the nucleus and can't enter the cytoplasm. "By understanding how messenger RNA exits the nucleus, we may be able to develop treatments for myotonic dystrophy and other disorders in which messenger RNA transport is blocked," he said.


'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert  

Page: 1 2 3

Related biology technology :

1. Quantum computer a stage closer with silicon breakthrough, reports Nature journal
2. Study sheds light into the nature of embryonic stem cells
3. Muscular protein bond -- strongest yet found in nature
4. Nature parks can save species as climate changes
5. Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species
6. Cell Biosciences Announces Publication in Nature Medicine
7. Nature Medicine study shows Peregrines bavituximab can cure lethal virus infections
8. Nature Reviews Publishes Article About Jennerexs Multi-Mechanistic Cancer Therapeutic
9. Light-speed nanotech: Controlling the nature of graphene
10. Data Published in Nature Cell Biology Reveal Novel Function of Drug Target EpCAM in Cancer Cell Signalling
11. Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nature study shows how molecules escape from the nucleus
(Date:4/16/2015)... 2015 Avelas Biosciences, an in vivo ... announced today that it has initiated a Phase 1b ... women with primary, non-recurrent breast cancer undergoing surgery. In ... addition of Steven Chen , M.D., as vice ... dose escalation study will enroll up to 39 women ...
(Date:4/16/2015)... Switzerland , April 16, ... part of Debiopharm Group ™ , a Swiss-based ... target unmet medical needs as well as ... on the investigational compounds Debio 1143 (SMAC mimetic) ... presented at the 2015 Annual meeting of ...
(Date:4/16/2015)... Madison, NJ (PRWEB) April 16, 2015 ... recruited Dr. Joseph V. Gulfo to become the ... and Entrepreneurship. Simultaneously, FDU announced the kick-off of ... new program spearheaded by Dr. Gulfo, under the ... Silberman College of Business) and in collaboration with ...
(Date:4/16/2015)... Dana-Farber Cancer Institute and its Belfer ... Inc. today announced the successful completion of a ... ready, Next Generation Sequencing (NGS) assay for non-small ... first to demonstrate the successful sequencing of clinically ... plasma samples and highlights the ability to discover ...
Breaking Biology Technology:Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 2Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 3Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 2Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 3
... - Five years removed from the dotcom bubble, when ... value of the online world, new business models that ... progressive in their cutting-edge approach to business and traditional ... picture of those business models was made clearer by ...
... Seven months after Journal Communications announced ... its shareholders, the company has instead decided to sell ... , ,Q-Comm and Journal Communications have signed a definitive ... the stock of Norlight, subject to federal and state ...
... shape, the issue of Net Neutrality will likely surface at ... all indications, U.S. Reps. John Dingell , D-Michigan, and ... issue to the 2007 legislative agenda. , ,Even Rep. ... has weighed in that something needs to be done. The ...
Cached Biology Technology:Web-centric entrepreneurs find models that attract investment 2Web-centric entrepreneurs find models that attract investment 3Web-centric entrepreneurs find models that attract investment 4Web-centric entrepreneurs find models that attract investment 5Journal to sell Norlight Telecommunications 2Net neutrality: To control or not control, that is the question 2Net neutrality: To control or not control, that is the question 3
(Date:3/31/2015)... March 31, 2015   Guidepoint , a leading ... the Post-Surgical Pain Management TRACKER, part of the ... trends in the medical device and therapeutics markets. The ... including treatment volumes, market share, and adoption rates across ... with joint surgery. The Post-Surgical Pain Management ...
(Date:3/24/2015)... 24, 2015   NexID Biometrics LLC, whose ... needs, today announced the beginning of shipments of version ... The company, based in Potsdam, N.Y. ... Connect:ID Expo, which began here today at the Walter ... 2.0 of its SDK boosts the accuracy rate range ...
(Date:3/23/2015)... --NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, announces its biometric payment technology, the Wocket® smart wallet, ... March 30 th . The new ... York markets. Gino Pereira ... new ad campaign following the recent initial shipment of Wocket ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3
... Scientists at the Salk Institute for Biological Studies ... plants to adapt to various environments, but could also benefit ... March 6 in Nature , the findings show that ... world, their epigenomic makeup is as varied as the environments ...
... (CUMC) researchers have found the first evidence that selective ... hippocampus, can reduce anxiety without affecting learning. The findings ... be used to treat certain anxiety disorders, such as ... cognitive side effects. The study, conducted in mice, was ...
... MA "Use it or lose it." The saying ... to protecting against Alzheimer,s disease. Previous studies have shown ... may help delay the onset of dementia in Alzheimer,s ... Dennis Selkoe, MD, co-director of the Center for Neurologic ...
Cached Biology News:Hidden layer of genome unveils how plants may adapt to environments throughout the world 2Hidden layer of genome unveils how plants may adapt to environments throughout the world 3Portion of hippocampus found to play role in modulating anxiety 2Portion of hippocampus found to play role in modulating anxiety 3Use it or lose it 2